Ming-Ren MA, Qiao-Mei CHEN, Xiao-Qing CAI, Pei-Qi JIAO, Fei WANG, Ling MA, Jia SONG, Yan LIU. Research progress of NLRP3 inflammasome inhibitors in cardiovascular diseases[J]. Chinese Heart Journal, 2023, 35(1): 88-93, 98. DOI: 10.12125/j.chj.202204036
    Citation: Ming-Ren MA, Qiao-Mei CHEN, Xiao-Qing CAI, Pei-Qi JIAO, Fei WANG, Ling MA, Jia SONG, Yan LIU. Research progress of NLRP3 inflammasome inhibitors in cardiovascular diseases[J]. Chinese Heart Journal, 2023, 35(1): 88-93, 98. DOI: 10.12125/j.chj.202204036

    Research progress of NLRP3 inflammasome inhibitors in cardiovascular diseases

    • NLRP3 inflammasome is a kind of polyprotein complex, which provides a reaction platform for quickly inducing the inflammatory response to infection and sterile injury. Studies have shown that NLRP3 inflammasome is involved in the occurrence and development of cardiovascular events, and the research and development of its inhibitors have become a hotspot in the field of cardiovascular disease treatment. Taking NLRP3 as the starting point, this paper summarizes the activation mechanism, key regulatory role of NLRP3 in the cardiovascular system and the latest research progress of NLRP3 inflammasome inhibitors, in order to provide reference for the research and development of anti-inflammatory drugs targeting NLRP3 inflammasome for cardiovascular diseases.
    • loading

    Catalog

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return